Dimitris Repantis

Dimitris Repantis, a psychiatrist, psychotherapist and researcher, leads the Psychedelic Substances Research Group at Charité – Universitätsmedizin Berlin. His research focuses on conducting clinical trials with psychedelic substances to develop novel treatments for individuals living with psychiatric conditions. Concurrently, he leads interdisciplinary research that explores the ethical, legal, and social aspects of psychedelic therapy and research, acknowledging the transformative potential of these substances, their current use outside of medicine, and their historical usage.